Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹11,689 Cr
Revenue (TTM)
₹668 Cr
Net Profit (TTM)
₹168 Cr
ROE
79.3 %
ROCE
104.3 %
P/E Ratio
69.5
P/B Ratio
36.3
Industry P/E
--
EV/EBITDA
42.4
Div. Yield
1.1 %
Debt to Equity
0
Book Value
₹139.8
EPS
₹74.4
Face value
10
Shares outstanding
23,030,622
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sanofi Consumer Healthcare India
| 2.6 | 1.8 | 5.3 | 676.1 | -- | -- | -- |
|
BSE Healthcare
| -4.6 | 0.9 | 5.1 | 17.0 | 27.1 | 21.6 | 10.3 |
|
BSE Small Cap
| -4.4 | 1.8 | 13.8 | 1.9 | 29.5 | 33.7 | 17.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sanofi Consumer Healthcare India
|
5,055.0 | 11,688.5 | 667.6 | 168.3 | 37.0 | 82.8 | 69.5 | 36.3 |
| 22.9 | 56.0 | 85.5 | 8.7 | -- | 0 | -- | 1.2 | |
| 243.8 | 3,816.1 | 2,711.5 | 3.2 | 6.5 | 0.5 | -- | 0.7 | |
| 48.3 | 14.8 | 0.8 | 0.4 | 50.5 | 9 | 41.6 | 3.8 | |
| 113.7 | 405.8 | 138.5 | 7.9 | 8.1 | 7.9 | 50.6 | 3.9 | |
| 240.0 | 10,896.3 | 2,622.8 | 382.6 | 17.0 | 16 | 28.6 | 4.4 | |
| 30.1 | 902.4 | 1,006.4 | 46.5 | 8.0 | 11 | 19.4 | 2.0 | |
| 765.3 | 15,968.9 | 1,465.2 | 82.8 | -- | 9 | 93.9 | 7.5 | |
| 8.5 | 123.4 | 0.0 | 37.5 | -- | -- | 3.3 | 6.0 | |
| 37.0 | 70.7 | 46.7 | 7.3 | 24.6 | 10.6 | 9.7 | 0.9 |
No Review & Analysis are available.
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal,... Baralgan, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited is a subsidiary of Sanofi India Limited. Read more
Incorporated
2023
Chairman
Amit Jain
Managing Director
Himanshu Bakshi
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Sanofi Consumer Healthcare India Ltd stood at ₹ 431 Cr as on 31-Mar-25
The share price of Sanofi Consumer Healthcare India Ltd is ₹5,055.00 (NSE) and ₹5,075.20 (BSE) as of 20-Jun-2025 IST. Sanofi Consumer Healthcare India Ltd has given a return of 676.13% in the last 1 years.
Sanofi Consumer Healthcare India Ltd has a market capitalisation of ₹ 11,689 Cr as on 20-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Sanofi Consumer Healthcare India Ltd is 69.45 times as on 20-Jun-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Sanofi Consumer Healthcare India Ltd and enter the required number of quantities and click on buy to purchase the shares of Sanofi Consumer Healthcare India Ltd.
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, Baralgan, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited is a subsidiary of Sanofi India Limited.
The promoter of Sanofi Consumer Healthcare India Ltd is Opella Healthcare Participations B.V.. Opella Healthcare Participations B.V. owns 60.4 per cent of the total equity. The chairman of the company is Amit Jain , and the managing director is Himanshu Bakshi..
There is no promoter pledging in Sanofi Consumer Healthcare India Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,896
|
|
|
3,816
|
|
|
902
|
|
|
406
|
|
|
123
|
|
|
71
|
|
|
56
|
|
|
15
|
|
|
15,969
|
| Sanofi Consumer Healthcare India Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
82.76
|
|
Operating margin(%)
|
37.03
|
|
Net Margin(%)
|
24.65
|
|
Dividend yield(%)
|
1.08
|
Yes, TTM profit after tax of Sanofi Consumer Healthcare India Ltd was ₹168 Cr.
₹43.50
(
